Ubs Group Ag Arca Biopharma, Inc. Transaction History

Ubs Group Ag

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.7 - $2.05 $1,710 - $2,062	1,006 Added 804.8%	1,131 $1,000
Q3 2023 Nov 09, 2023	BUY	$2.01 - $2.07 $251 - $258	125 New	125 $0
Q1 2023 May 12, 2023	BUY	$1.99 - $2.55 $567 - $726	285 Added 18.97%	1,787 $3,000
Q4 2022 Feb 08, 2023	SELL	$1.86 - $25.8 $2,077 - $28,818	-1,117 Reduced 42.65%	1,502 $3,000
Q3 2022 Nov 10, 2022	SELL	$2.13 - $25.68 $4,047 - $48,792	-1,900 Reduced 42.04%	2,619 $5,000
Q2 2022 Aug 10, 2022	SELL	$2.2 - $2.53 $1,115 - $1,282	-507 Reduced 10.09%	4,519 $11,000
Q1 2022 May 16, 2022	SELL	$1.77 - $2.49 $4,527 - $6,369	-2,558 Reduced 33.73%	5,026 $12,000
Q4 2021 Feb 14, 2022	BUY	$2.15 - $2.97 $16,305 - $22,524	7,584 New	7,584 $16,000
Q3 2021 Nov 15, 2021	SELL	$2.77 - $3.74 $14,861 - $20,065	-5,365 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.06 - $3.9 $16,416 - $20,923	5,365 New	5,365 $19,000
Q1 2021 May 12, 2021	SELL	$3.48 - $5.3 $5,348 - $8,146	-1,537 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$3.74 - $5.18 $2,281 - $3,159	610 Added 65.8%	1,537 $6,000
Q3 2020 Nov 12, 2020	BUY	$4.07 - $7.99 $3,772 - $7,406	927 New	927 $4,000
Q2 2020 Jul 31, 2020	SELL	$2.69 - $19.21 $83 - $595	-31 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$2.32 - $6.42 $7,024 - $19,439	-3,028 Reduced 98.99%	31 $0
Q4 2019 Feb 14, 2020	BUY	$4.95 - $5.96 $15,142 - $18,231	3,059 New	3,059 $17,000
Q3 2019 Nov 14, 2019	SELL	$4.95 - $7.2 $8,969 - $13,046	-1,812 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.15 - $15.1 $9,331 - $27,361	1,812 New	1,812 $13,000

280K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.